Jefferies sees Novo dropping ‘at least’ 10%-15% on obesity data
Jefferies analyst Peter Welford says the first headline from Novo Nordisk’s Phase III CagriSema obesity data “disappoint” with 20.4% absolute weight loss and patient adherence...
Author : The Fly
Novo Nordisk: Cagrisema shows ‘superior’ weight loss in REDEFINE 1 trial
Novo Nordisk announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE program. REDEFINE 1 is a 68-week efficacy and safety...
Biogen just downgraded at BMO Capital, here’s why
BMO Capital downgraded Biogen to Market Perform from Outperform with a price target of $164, down from $230. Work is underway at Biogen, but “efforts...
Affirm just upgraded at JMP Securities, here’s why
JMP Securities analyst David Scharf upgraded Affirm to Outperform from Market Perform with a $78 price target. The analyst believes Affirm is a “long-term secular...
Closing Bell Movers: Nike flat as guidance undermines earnings beat
Check out this evening’s top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGS… To see the rest of the story go...
What You Missed On Wall Street On Thursday
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1… To see the rest of the...
Analysts say TripAdvisor deal could be precursor to more value-creating moves
Shares of TripAdvisor (TRIP) jumped on Thursday after the company announced plans to buy Liberty TripAdvisor Holdings (LTRPA) in a deal valued at about $435M....
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Neurocrine Biosciences… To see the...
Micron sinks on guidance, TripAdvisor to buy Liberty TripAdvisor: Morning Buzz
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1… To see the rest of the...
Rising High: Exclusive talk with biopharma company HMNC Brain Health
In this edition of “Rising High,” The Fly conducted an exclusive interview with Hans Eriksson, Chief Medical Officer of HMNC Brain Health, a global precision...